Baseline characteristic | Dose of stavudine | |
---|---|---|
 | 40 mg n = 2445 | 30 mg n = 1465 |
Weight†| 67.0 (62.8-74.0) | 68.1 (63.6-75.6) |
Age†| 37 (32-43) | 38 (33-44) |
Male gender | 1017(41.6) | 628 (42.9) |
African ethnicity | 2,348 (96.0) | 1,416 (96.7) |
Employed | 1,130 (46.2) | 855 (58.4) |
Tuberculosis | 364 (14.9) | 155 (10.6) |
Haemoglobin (low) | 823 (35.0) | 433 (29.8) |
WHO stage III or IV | 956 (39.1) | 356 (24.3) |
CD4 count (cells/mm3)†| 97 (39-163) | 137 (66-192) |
Efavirenz-based HAART | 2203 (90.1) | 1296 (88.5) |
Nevirapine-based HAART | 193 (7.9) | 116 (7.9) |